Atnaujinkite slapukų nuostatas

El. knyga: Cancer Vaccination and Challenges: Volume 1: Strategies for Therapeutic Cancer Vaccine Development

Edited by , Edited by , Edited by
  • Formatas: 416 pages
  • Išleidimo metai: 22-Nov-2024
  • Leidėjas: Apple Academic Press Inc.
  • Kalba: eng
  • ISBN-13: 9781040098226
  • Formatas: 416 pages
  • Išleidimo metai: 22-Nov-2024
  • Leidėjas: Apple Academic Press Inc.
  • Kalba: eng
  • ISBN-13: 9781040098226

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Discusses cancer vaccines and challenges their development and delivery present. Details techniques for the development of therapeutic cancer vaccines. Clarifies the need for vaccines also providing latest insights on DNA- and RNA-based cancer vaccines, and the regulatory perspectives for the cancer vaccine developments.



Volume 1: Strategies for Therapeutic Cancer Vaccine Development deals with different strategies of cancer vaccine development, focusing on techniques for the development of therapeutic cancer vaccines and the roles of tumor antigens, proteins/peptides, microbial genes, and stem cells for the development of vaccines for cancer management.

Volume 2: Delivery Strategies for Cancer Vaccine and Immunotherapy in Management of Various Carcinomas covers delivery strategies of cancer vaccines for the management of various forms of carcinoma, examining the prospects of delivering immuno-oncology therapies, focusing specifically on the effective drug delivery strategies for treatment of lung, prostate, and pancreatic carcinomas.

Recenzijos

A comprehensive guide to cancer vaccine research. . . . cover[ s] every aspect of cancer immunology and vaccine development . . . and explores the most successful and promising approaches by incorporating the latest studies on preventive and therapeutic cancer vaccination. The book offers up-to-date information on various topics, including tumor antigens for cancer vaccines, strategies, approaches, advancements, difficulties, and challenges in vaccine development for cancer treatment. Recent advances in DNA and RNA-based vaccines for cancer prevention and treatment are thoroughly discussed in this volume. This compendium enables researchers and practitioners to easily access the comprehensive concept of cancer vaccines and their implications in healthcare. . . . An essential resource in disseminating the vast and expanding literature on cancer immunization and vaccine development. From the Foreword by Harish Padh, Former Vice-Chancellor, Sardar Patel University, Vallabh Vidyanagar, Anand, Gujarat, India; Former Director, B. V. Patel Pharmaceutical Education and Research Development (PERD), Ahmedabad, Gujarat, India

1. Cancer Vaccines: Types, Mechanisms, and Recent Developments
2.
Strategies to Develop Cancer Vaccines
3. Role of Tumor Antigens for Cancer
Vaccine Development
4. DNA-Based Cancer Vaccine: Advancements and Challenges
5. RNA-Based Cancer Vaccines: Advancements and Challenges
6. Utilization of
Microbial Genes as a Vaccine Against Cancer
7. Utilization of Protein and
Peptides as Cancer Vaccines: Advancements and Challenges Assessment of
Ethnomedical Plants: Shiwalik Hills, Himachal Pradesh, India
8. Stem
Cell-Based Cancer Vaccines as Promising Immuno-therapy: Current Progress and
Challenges
9. Preventive Cancer Vaccine
10. Providing Cognitive Platforms for
the Effectiveness of Cancer Vaccines
11. Survival Data and Therapeutic
Outcomes of Cancer Vaccines
12. Regulatory Considerations for Cancer Vaccines
Development
Rishabha Malviya, PhD, has 11 years of research experience and is presently working as Associate Professor of Pharmacy, School of Medical and Allied Sciences, Galgotias University, India. He has authored over 150 research and review papers and book chapters and edited 13 books to date. He has been included in the Worlds Top 2% Scientists list by Elsevier BV and Stanford University. He is a reviewer, editor, and editorial board member of more than 50 national and international journals.

Bhupendra Prajapati, PhD, is a Professor of Pharmaceutics at Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, India. He has more than 20 years of academic and research experience and has published more than 100 research and review papers, edited three books, and authored 20 book chapters on novel drug delivery. He has also published two Indian patents and has three applications under evaluation. He is a reviewer for three high-impact journals and is on the editorial boards of several scientific journals.

Sonali Sundram, PhD, is Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, India. Previously, she was a research scientist on a project of the Indian Council of Medical Research (ICMR) at King Georges Medical University, Lucknow, India. After that, she joined BBDNIIT (Babu Banarasi Das Northern India Institute of Technology), Lucknow. She has authored or edited 14 books and has organized several national and international seminars, conferences, and workshops. She has more than eight patents, both national and international, to her credit